Tradename | Company | Number | Date | Products |
---|---|---|---|---|
VISIPAQUE 270 | GE Healthcare | N-020351 RX | 1996-03-22 | 1 products, RLD, RS |
VISIPAQUE 320 | GE Healthcare | N-020351 RX | 1996-03-22 | 1 products, RLD, RS |
VISIPAQUE 320 | GE Healthcare | N-020808 RX | 1997-08-29 | 1 products |
Brand Name | Status | Last Update |
---|---|---|
visipaque | New Drug Application | 2024-01-11 |
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
---|---|---|---|---|---|---|---|---|---|
Coronary artery disease | D003324 | — | I25.1 | — | — | 2 | 6 | 5 | 13 |
Chronic renal insufficiency | D051436 | — | N18 | — | — | — | 5 | 2 | 7 |
Renal insufficiency | D051437 | HP_0000083 | N19 | — | — | 1 | 6 | — | 7 |
Healthy volunteers/patients | — | — | — | 2 | 1 | — | 1 | — | 3 |
Coronary stenosis | D023921 | EFO_1000882 | — | — | — | — | 3 | — | 3 |
Diabetes mellitus | D003920 | HP_0000819 | E08-E13 | — | — | — | 3 | — | 3 |
Lung neoplasms | D008175 | HP_0100526 | C34.90 | — | — | — | 1 | 1 | 2 |
Pulmonary embolism | D011655 | HP_0002204 | I26 | — | — | — | 2 | — | 2 |
Renal artery obstruction | D012078 | EFO_1001150 | N28.0 | — | — | — | 1 | 1 | 2 |
Chronic kidney failure | D007676 | EFO_0003884 | N18.6 | — | — | — | 2 | — | 2 |
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
---|---|---|---|---|---|---|---|---|---|
Acute kidney injury | D058186 | HP_0001919 | N17 | 1 | — | 1 | — | 1 | 3 |
Cardiovascular diseases | D002318 | HP_0001626 | — | — | — | 1 | — | — | 1 |
Hyperlipidemias | D006949 | HP_0003077 | E78.5 | — | — | 1 | — | — | 1 |
Ischemic stroke | D000083242 | — | — | — | — | 1 | — | — | 1 |
Atherosclerosis | D050197 | EFO_0003914 | I25.1 | — | — | 1 | — | — | 1 |
Carotid stenosis | D016893 | — | — | — | — | 1 | — | — | 1 |
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
---|---|---|---|---|---|---|---|---|---|
Pancreatic neoplasms | D010190 | EFO_0003860 | C25 | — | — | — | — | 2 | 2 |
Cardio-renal syndrome | D059347 | — | — | — | — | — | — | 2 | 2 |
Glioblastoma | D005909 | EFO_0000515 | — | — | — | — | — | 1 | 1 |
Myocardial infarction | D009203 | EFO_0000612 | I21 | — | — | — | — | 1 | 1 |
Non-small-cell lung carcinoma | D002289 | — | — | — | — | — | — | 1 | 1 |
Small cell lung carcinoma | D055752 | — | — | — | — | — | — | 1 | 1 |
Mesothelioma | D008654 | — | C45 | — | — | — | — | 1 | 1 |
Pancreatitis | D010195 | HP_0001733 | K85 | — | — | — | — | 1 | 1 |
St elevation myocardial infarction | D000072657 | — | — | — | — | — | — | 1 | 1 |
Otitis media with effusion | D010034 | EFO_0007415 | H65.3 | — | — | — | — | 1 | 1 |
Drug common name | Iodixanol |
INN | iodixanol |
Description | Iodixanol is a dimeric, non-ionic, water-soluble, radiographic contrast agent, used particularly in coronary angiography. It has a role as a radioopaque medium. |
Classification | Small molecule |
Drug class | iodine-containing contrast media |
Image (chem structure or protein) | |
Structure (InChI/SMILES or Protein Sequence) | CC(=O)N(CC(O)CN(C(C)=O)c1c(I)c(C(=O)NCC(O)CO)c(I)c(C(=O)NCC(O)CO)c1I)c1c(I)c(C(=O)NCC(O)CO)c(I)c(C(=O)NCC(O)CO)c1I |
PDB | — |
CAS-ID | 92339-11-2 |
RxCUI | — |
ChEMBL ID | CHEMBL1200507 |
ChEBI ID | 31705 |
PubChem CID | 3724 |
DrugBank | DB01249 |
UNII ID | HW8W27HTXX (ChemIDplus, GSRS) |